Crop protection start-up Ascribe Bioscience has raised a $2.5M Seed Round co-led by The Yield Lab and Acre Venture Partners. Impact-oriented investors Trailhead Capital and Ponderosa Ventures also participated in the financing. The investment will enable Ascribe to accelerate commercial development of their lead product Phytalix: an environmentally-friendly, broad spectrum biopesticide based on a naturally-occurring small molecule from the soil microbiome.

Ascribe Bioscience, Inc. discovers and develops natural crop protection products based on small molecules from the soil microbiome. Ascribe’s platform technology is based on discoveries from the Boyce Thompson Institute at Cornell University. The company’s biopesticide and biostimulant products enable farmers to combat disease and improve plant health without harming the environment. To learn more, visit www.ascribebio.com

Ascribe Bioscience Raises $2.5M Seed Round, Accelerates Trials Of Natural Crop Protection Product

Description

Company Information

Ascribe Bioscience Raises $2.5M Seed Round, Accelerates Trials Of Natural Crop Protection Product

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information